Literature DB >> 32207408

Functional assessment of coronary stenosis with angiography-based Quantitative Flow Ratio compared with Fractional Flow Reserve in patients with severe aortic stenosis.

Hernán Mejía-Rentería1, Luis Nombela-Franco, Jean-Michel Paradis, Mattia Lunardi, Joo Myung Lee, Ignacio J Amat-Santos, Gabriela Veiga Fernandez, Ankur Kalra, Eric J Bansal, Jose Maria de la Torre Hernandez, Josep Rodés-Cabau, Flavio L Ribichini, Javier Escaned.   

Abstract

AIMS: To investigate the diagnostic performance of quantitative flow ratio (QFR) in assessing the physiological relevance of coronary lesions in the presence of severe aortic valve stenosis (SAS). METHODS AND
RESULTS: 115 SAS patients (138 coronary arteries) were included. Functional assessment of coronary stenoses was performed with fractional flow reserve (FFR) before transcatheter aortic-valve implantation (TAVI). Subsequently, QFR was calculated at a central core laboratory, blinded to FFR results. The diagnostic yield of QFR was assessed using FFR as reference. Coronary stenoses were intermediate (diameter stenosis 48±10%, FFR 0.84 [0.77-0.89], QFR 0.82 [0.73-0.89]). Per-vessel sensitivity, specificity, area under the ROC curve and accuracy of QFR were 84% (95% CI 71-92%), 80% (95% CI 69-88%), 0.88 (95% CI 0.82-0.93) and 81%, respectively. Diagnostic accuracy of QFR significantly decreased in patients with aortic valve area (AVA) <0.60 cm2. Diagnostic performance of QFR was superior to angiography in assessing the FFR-based functional significance (AUC 0.88 [95% CI 0.82-0.93] vs. 0.74 [95% CI 0.66-0.81], respectively; p = 0.0002).
CONCLUSIONS: Compared with FFR, QFR has a good diagnostic yield and is superior to angiography in assessing the functional relevance of coronary lesions in SAS patients awaiting TAVI, particularly when AVA is ≥0.6 cm2.

Entities:  

Year:  2020        PMID: 32207408     DOI: 10.4244/EIJ-D-19-01001

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  6 in total

1.  Diagnostic performance of quantitative flow ratio, non-hyperaemic pressure indices and fractional flow reserve for the assessment of coronary lesions in severe aortic stenosis.

Authors:  Cameron Dowling; Michael Michail; Jun Michael Zhang; Andrea Comella; Udit Thakur; Robert Gooley; Liam McCormick; Adam J Brown; Dennis T L Wong
Journal:  Cardiovasc Diagn Ther       Date:  2022-06

Review 2.  Evolving Indications of Transcatheter Aortic Valve Replacement-Where Are We Now, and Where Are We Going.

Authors:  Jules Mesnier; Vassili Panagides; Jorge Nuche; Josep Rodés-Cabau
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

3.  Characterization of quantitative flow ratio and fractional flow reserve discordance using doppler flow and clinical follow-up.

Authors:  Jelmer Westra; Ashkan Eftekhari; Mick Renkens; Hernán Mejía-Rentería; Martin Sejr-Hansen; Valérie Stegehuis; Niels Ramsing Holm; Robert-Jan de Winter; Jan J Piek; Javier Escaned; J J Wykrzykowska; Evald Høj Christiansen
Journal:  Int J Cardiovasc Imaging       Date:  2022-01-18       Impact factor: 2.357

4.  Feasibility and Comparison of Resting Full-Cycle Ratio and Computed Tomography Fractional Flow Reserve in Patients with Severe Aortic Valve Stenosis.

Authors:  Hendrik Wienemann; Marcel C Langenbach; Victor Mauri; Maryam Banazadeh; Konstantin Klein; Christopher Hohmann; Samuel Lee; Isabel Breidert; Alexander Hof; Kaveh Eghbalzadeh; Elmar Kuhn; Marcel Halbach; David Maintz; Stephan Baldus; Alexander Bunck; Matti Adam
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-14

Review 5.  Fractional Flow Reserve: Patient Selection and Perspectives.

Authors:  Joyce Peper; Leonie M Becker; Jan-Peter van Kuijk; Tim Leiner; Martin J Swaans
Journal:  Vasc Health Risk Manag       Date:  2021-12-14

Review 6.  Coronary Artery Disease in Patients with Aortic Stenosis and Transcatheter Aortic Valve Implantation: Implications for Management.

Authors:  Antonio Fb de Azevedo Filho; Tarso Ad Accorsi; Henrique B Ribeiro
Journal:  Eur Cardiol       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.